Analyst Predicts Black Box Warning For Byetta

Law360 (September 3, 2008, 12:00 AM EDT) -- Amid cases of severe pancreatitis in patients taking the diabetes drug Byetta — and two deaths linked to the injectable medication — a financial analyst said Tuesday that the U.S. Food and Drug Administration might soon require a top-level warning label.

"We think Byetta could get a black box pancreatitis warning," analyst Adam Cutler of Canaccord Adams Inc. said in a research note, which also stated that “the FDA suspects Byetta causes pancreatitis.”

Amylin Pharmaceuticals had no immediate comment on the matter Wednesday.

In a statement...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.